학술논문
A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study
Document Type
Article
Author
Kupczyk, Maciej; Majak, Paweł; Kuna, Piotr; Asankowicz-Bargiel, Beata; Barańska, Eliza; Dobek, Rafał; Garbicz, Sławomir; Jerzyńska, Joanna; Latos, Anna; Machowiak, Wojciech; Majorek-Olechowska, Bernadetta; Olech-Cudzik, Anna; Poziomkowska-Gęsicka, Iwona; Rulewicz-Warniełło, Mirosława; Świderska, Anna; Tarnowski, Michał; Kopyto, Przemysław
Source
In Respiratory Medicine January 2021 176
Subject
Language
ISSN
0954-6111